- Home
- ORIC vs CSR Comparison
ORIC vs CSR Comparison
Compare ORIC & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- CSR
- Stock Information
- Founded
- ORIC 2014
- CSR 1970
- Country
- ORIC United States
- CSR United States
- Employees
- ORIC N/A
- CSR N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- CSR Real Estate Investment Trusts
- Sector
- ORIC Health Care
- CSR Real Estate
- Exchange
- ORIC Nasdaq
- CSR Nasdaq
- Market Cap
- ORIC 974.1M
- CSR 997.0M
- IPO Year
- ORIC 2020
- CSR N/A
- Fundamental
- Price
- ORIC $10.88
- CSR $60.52
- Analyst Decision
- ORIC Strong Buy
- CSR Buy
- Analyst Count
- ORIC 10
- CSR 7
- Target Price
- ORIC $17.33
- CSR $70.00
- AVG Volume (30 Days)
- ORIC 782.2K
- CSR 98.4K
- Earning Date
- ORIC 08-12-2025
- CSR 10-27-2025
- Dividend Yield
- ORIC N/A
- CSR 5.16%
- EPS Growth
- ORIC N/A
- CSR N/A
- EPS
- ORIC N/A
- CSR N/A
- Revenue
- ORIC N/A
- CSR $267,076,000.00
- Revenue This Year
- ORIC N/A
- CSR $5.37
- Revenue Next Year
- ORIC N/A
- CSR $3.01
- P/E Ratio
- ORIC N/A
- CSR N/A
- Revenue Growth
- ORIC N/A
- CSR 3.44
- 52 Week Low
- ORIC $3.90
- CSR $52.76
- 52 Week High
- ORIC $14.67
- CSR $76.16
- Technical
- Relative Strength Index (RSI)
- ORIC 63.04
- CSR 65.77
- Support Level
- ORIC $9.87
- CSR $57.07
- Resistance Level
- ORIC $10.35
- CSR $59.68
- Average True Range (ATR)
- ORIC 0.44
- CSR 1.17
- MACD
- ORIC 0.14
- CSR 0.51
- Stochastic Oscillator
- ORIC 79.99
- CSR 93.18
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About CSR D/B/A Centerspace
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.